MedTrace Logo

Prevalence and Risk Factors of Women Mental Health Disorders

NCT04792671 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-03-11

No results posted yet for this study

Summary

Perinatal major depressive disorder affects 20% of women, while perinatal anxiety affects 10% of women. Although pharmacological treatment has shown effectiveness, many pregnant women are concerned about potential adverse effects on the fetus, maternal-infant bonding, and child development.. On the other hand, Depressive disorder in women mainly occurs during the first year after childbirth. It takes many forms according to the onset, severity, and duration of the symptoms including; Postpartum blues (PPB), Postpartum depression (PPD), and Postpartum psychosis (PPP). Lack of access to mental health services during the perinatal period is a significant public health concern that may worse outcome.

So, we aimed to study prevalence of women mental health in Assiut governorate and evaluate possible risk factor for it

Conditions

  • Psychiatric Problem
  • Wolman Disease

Interventions

BEHAVIORAL

Sociodemographic variables

age, residence, education of the mother and her husband, occupation of the mother and her husband, parity, gender, and age of the last baby.

BEHAVIORAL

Family affluence scale (FAS)

a four-item measure of family wealth, has been developed in the WHO Health Behaviour in School-aged Children Study as an alternative measure.

BEHAVIORAL

Edinburgh postnatal depression scale (EPDS)

s a questionnaire originally developed to assist in identifying possible symptoms of depression in the postnatal period. It also has adequate sensitivity and specificity to identify depressive symptoms in the antenatal period and is useful in identifying symptoms of anxiety. more than 9 is clinically diagnosed

BEHAVIORAL

Symptom Checklist 90 "SCL 90":

is a 90-item questionnaire used to assess psychological problems. It is designed to evaluate a broad range of psychological problems and symptoms of psychopathology. More than 60 is considered clinically diagnosed

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2022-09-01
Completion
2023-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04792671 on ClinicalTrials.gov